India · Delayed Price · Currency is INR Medicamen Biotech Statistics
Total Valuation
NSE:MEDICAMEQ has a market cap or net worth of INR 3.12 billion. The enterprise value is 3.28 billion.
| Market Cap | 3.12B |
| Enterprise Value | 3.28B |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | Sep 19, 2025 |
Share Statistics
| Current Share Class | 12.71M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.67% |
| Shares Change (QoQ) | -34.94% |
| Owned by Insiders (%) | 7.06% |
| Owned by Institutions (%) | 0.69% |
| Float | 3.85M |
Valuation Ratios
The trailing PE ratio is 32.35.
| PE Ratio | 32.35 |
| Forward PE | n/a |
| PS Ratio | 1.55 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.47, with an EV/FCF ratio of -8.65.
| EV / Earnings | 34.06 |
| EV / Sales | 1.63 |
| EV / EBITDA | 14.47 |
| EV / EBIT | 21.21 |
| EV / FCF | -8.65 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.54 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | -1.26 |
| Interest Coverage | 4.43 |
Financial Efficiency
Return on equity (ROE) is 4.01% and return on invested capital (ROIC) is 4.50%.
| Return on Equity (ROE) | 4.01% |
| Return on Assets (ROA) | 2.89% |
| Return on Invested Capital (ROIC) | 4.50% |
| Return on Capital Employed (ROCE) | 5.45% |
| Weighted Average Cost of Capital (WACC) | 7.44% |
| Revenue Per Employee | 5.34M |
| Profits Per Employee | 256,418 |
| Employee Count | 376 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, NSE:MEDICAMEQ has paid 21.88 million in taxes.
| Income Tax | 21.88M |
| Effective Tax Rate | 18.26% |
Stock Price Statistics
The stock price has decreased by -42.04% in the last 52 weeks. The beta is 0.62, so NSE:MEDICAMEQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -42.04% |
| 50-Day Moving Average | 259.21 |
| 200-Day Moving Average | 327.86 |
| Relative Strength Index (RSI) | 36.44 |
| Average Volume (20 Days) | 24,843 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDICAMEQ had revenue of INR 2.01 billion and earned 96.41 million in profits. Earnings per share was 7.11.
| Revenue | 2.01B |
| Gross Profit | 991.11M |
| Operating Income | 154.82M |
| Pretax Income | 119.84M |
| Net Income | 96.41M |
| EBITDA | 227.00M |
| EBIT | 154.82M |
| Earnings Per Share (EPS) | 7.11 |
Balance Sheet
The company has 312.64 million in cash and 477.84 million in debt, with a net cash position of -165.19 million.
| Cash & Cash Equivalents | 312.64M |
| Total Debt | 477.84M |
| Net Cash | -165.19M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.76B |
| Book Value Per Share | 234.32 |
| Working Capital | 1.36B |
Cash Flow
In the last 12 months, operating cash flow was -331.72 million and capital expenditures -47.78 million, giving a free cash flow of -379.50 million.
| Operating Cash Flow | -331.72M |
| Capital Expenditures | -47.78M |
| Depreciation & Amortization | 72.19M |
| Net Borrowing | 145.31M |
| Free Cash Flow | -379.50M |
| FCF Per Share | n/a |
Margins
Gross margin is 49.34%, with operating and profit margins of 7.71% and 4.80%.
| Gross Margin | 49.34% |
| Operating Margin | 7.71% |
| Pretax Margin | 5.97% |
| Profit Margin | 4.80% |
| EBITDA Margin | 11.30% |
| EBIT Margin | 7.71% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.07% |
| Buyback Yield | -6.67% |
| Shareholder Yield | -6.28% |
| Earnings Yield | 3.09% |
| FCF Yield | -12.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |